I'm starting to nibble on NVTR neuromodulation stock the spin-off of GB. It's currently trading around $4.60. The company has 10.25 million shares outstanding. GB funded it with $75 million in cash, debt is around 10% of that figure. It has FDA approvals and should be ramping up sales this year. The stock has gotten trounced my guess is nobody wants a few shares, due to the 1 for 3 spin-off ratio and the market cap is low compared to GB. . Good management team. The company purchased a minority stake (11%) in it's main subsidiaries for $16.7 mil. in the 4th quarter of '15. Thereby valuing the whole at approx. $150 mil. The company is currently trading for a value of $50 mil. The only thing I don't like is the competitive space & the fact that GB is doing it's manufacturing. Take a look. I think it's interesting.
But MNKD doesn't have the cash to market it.. And Receptor Life Sciences is just a pretty webpage.
To whoever gave me a thumbs down for my idea. Sorry, just sold most of it @$6.20 for a $1.60 profit in 3 days. I'm curious why you didn't like it. Are you the CEO of NVRO?
I posted to the NVRO neuromodulation site. Thought on this and liked it @ $4.60. I'm taking a trade in the $6+ area on most & keeping some. Good luck to all!
That's fine & well, but the company needs to come through too. A short squeeze is just that without fundamentals. Most people on this board wouldn't sell anyway with some of the ridiculous price targets they've put out here.
Stop worrying about the shorts. Worry about who wants to go long more.
What a dreamer! $1k a share without any further dilution would give it a $500 billion market cap. MRK is only worth $160 bil. Stop the nonsense! If it gets back to $10 you should consider yourself very fortunate.
You really expect this to be worth 6 times more than the whole of MRK with a single drug? You should mortgage your house then, and load up the credit cards.
IBD article. What stupid people allowed this to be printed? First who talks about sequential sales? The important stat is year on year comparisons. All it took was one look at the NICS chart and it's easy to see that sales since 1999 have always gone down from March to April. In the meanwhile April 2016 sales ares 25% above last April's. C'mon guys its hard enough to read all that's out here let alone between the lines of poorly written articles. Retract the story or fix it!
Tough call. The jobs report will probably direct things the most. Hopefully someone reads between the lines of the article. I haven't followed how the SWHC or RGR have done after NICS #'s. I was mostly involved after the Newton tragedy & the stocks were getting bashed. I'm out of them now, but I still have them on my screen. Best of Luck. This management has done some incredible work.
O.K. whatever. I'm not involved. I was involved in a similar situation years ago, and I learned my lesson. There are too many rabid shareholders in MNKD at this point. Most have lost a lot of money. I wish you all well, but I wouldn't make this stock a central part of my investment portfolio. I feel like there has been quite a large number of people who have lost substantial sums.judging by the commentary alone.
There are a lot of people on this board who are shareholders who are completely detached from reality or pumpers. Unfortunately it makes it a wasteland, and just give false hopes to others. There is very little rational conversation.